Search Videos and More

Showing 1 - 12 of 28 results

Previous| 1 | 2 | 3 |Next


Dana-Farber Researchers Launch New Project to Investigate How Neighborhoods Contribute to Prostate Cancer Inequity News

Dana-Farber Researchers Launch New Project to Investigate How Neighborhoods Contribute to Prostate Cancer Inequity

Researchers at Dana-Farber Cancer Institute and the Rutgers University Cancer Institute are investigating what it is about neighborhoods that may increase a Black man’s risk of dying from prostate cancer.
Newly Identified Regulator in Prostate Cancer Cells Could Serve as Drug Target for Advanced Tumors News

Newly Identified Regulator in Prostate Cancer Cells Could Serve as Drug Target for Advanced Tumors

Aiming to discover new targets for blocking androgen receptor activity, a Dana-Farber-led team has identified a critical regulator of AR signaling that prostate cancer cells depend on, according to their publication in Cell Reports.
2022 GU ASCO Kidney Cancer Highlights Video

2022 GU ASCO Kidney Cancer Highlights

Kidney Cancer Highlights featuring Vincent Xu, MD and Toni Choueiri, MD
2022 GU ASCO Bladder Cancer Highlights Video

2022 GU ASCO Bladder Cancer Highlights

Bladder Cancer Highlights featuring Guru Sonpavde, MD
2022 GU ASCO Prostate Cancer Highlights Video

2022 GU ASCO Prostate Cancer Highlights

Prostate Cancer Highlights featuring Jacob Berchuck, MD and Chris Sweeney, MBBS
ASCO GU Symposium Highlights Symposium

ASCO GU Symposium Highlights

In the following videos, faculty from Dana-Farber Cancer Institute review highlights from the 2022 ASCO GU Symposium
Dana-Farber Research Supports FDA Approval of Immunotherapy Drug Given After Surgery for Certain Patients with Kidney Cancer News

Dana-Farber Research Supports FDA Approval of Immunotherapy Drug Given After Surgery for Certain Patients with Kidney Cancer

Pembrolizumab is the first drug approved as adjuvant therapy for patients with kidney cancer considered at high risk of relapse.
Rare Cancer: A Father's Journey with Medullary Kidney Cancer Video

Rare Cancer: A Father's Journey with Medullary Kidney Cancer

A father and Air Force recruiter details his journey at Dana-Farber Cancer Institute with medullary kidney cancer - a rare cancer disproportionately affecting African Americans.
Targeted Drug Shows Activity Against Brain Metastases in Kidney Cancer News

Targeted Drug Shows Activity Against Brain Metastases in Kidney Cancer

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet need.
Bladder Cancer Research at ESMO Video

Bladder Cancer Research at ESMO

Dana-Farber's Guru Sonpavde, MD, provides insight on circulating tumor DNA trial in bladder cancer highlighted at ESMO 2021.
Kidney Cancer Research at ESMO Video

Kidney Cancer Research at ESMO

Dana-Farber's Toni Choueiri, MD, provides insight on KEYNOTE-564 trial in kidney cancer highlighted at ESMO 2021.
Study Pairs Two Forms of Immunotherapy in Patients with Advanced Kidney Cancer News

Study Pairs Two Forms of Immunotherapy in Patients with Advanced Kidney Cancer

T cells revved up to attack tumors are turned into an army of loiterers. Cells keenly attuned to signals of infection or disease fail to pick up the faint notes of cancer. A clinical trial led by Dana-Farber researchers is addressing both of these issues in patients who have undergone surgery for kidney cancer but have a high risk of recurrence.

Showing 1 - 12 of 28 results

Previous| 1 | 2 | 3 |Next